Form D — CytoDyn Inc.
0001175680-26-000003 · filed 2026-05-11
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $18,600,392
- Total sold
- $18,600,392
- Minimum investment
- $15,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- CytoDyn Inc.
- CIK
- 1175680
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1111 MAIN STREET, SUITE 660
VANCOUVER, WA 98660 - Phone
- 360-980-8524
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jacob P. Lalezari · Executive OfficerVancouver, WA Find on LinkedIn ↗
-
Robert E. Hoffman · Executive OfficerVancouver, WA Find on LinkedIn ↗
-
Tyler Blok · Executive OfficerVancouver, WA Find on LinkedIn ↗
-
Lishomwa C. Ndhlovu, M.D., Ph.D. · DirectorVancouver, WA Find on LinkedIn ↗
-
Karen J. Brunke, Ph.D. · DirectorVancouver, WA Find on LinkedIn ↗
-
Ryan M. Dunlap · DirectorVancouver, WA Find on LinkedIn ↗
-
Tanya D. Urbach · DirectorVancouver, WA Find on LinkedIn ↗
-
Stephen M. Simes · DirectorVancouver, WA Find on LinkedIn ↗
View original on SEC EDGAR.